• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管三尖瓣植入患者的术后肺部并发症——对物理治疗师的启示

Postoperative Pulmonary Complications in Patients With Transcatheter Tricuspid Valve Implantation-Implications for Physiotherapists.

作者信息

Yu Peng-Ming, Wang Yu-Qiang, Luo Ze-Ruxing, Tsang Raymond C C, Tronstad Oystein, Shi Jun, Guo Ying-Qiang, Jones Alice Y M

机构信息

Rehabilitation Medicine Center, Sichuan University West China Hospital, Chengdu, China.

Key Laboratory of Rehabilitation Medicine in Sichuan Province, Chengdu, China.

出版信息

Front Cardiovasc Med. 2022 May 19;9:904961. doi: 10.3389/fcvm.2022.904961. eCollection 2022.

DOI:10.3389/fcvm.2022.904961
PMID:35665252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9160231/
Abstract

OBJECTIVES

To investigate the incidence of postoperative pulmonary complications (PPCs) and short-term recovery after transcatheter tricuspid valve implantation (TTVI).

METHODS

A total of 17 patients diagnosed with severe tricuspid regurgitation who received a LuX-valve TTVI were included in this study. Spirometry lung function, maximal inspiratory pressure (MIP), and 6-min walk test distance (6MWD) were recorded. Prior to surgery, patients were stratified into high or low pulmonary risk groups based on published predefined criteria. A physiotherapist provided all patients with education on thoracic expansion exercises, effective cough and an inspiratory muscle training protocol at 50% of MIP for 3 days preoperatively. All patients received standard post-operative physiotherapy intervention including positioning, thoracic expansion exercises, secretion removal techniques and mobilization. Patients were assessed for PPCs as defined by the Melbourne-Group Score-version 2. Clinical characteristics and hospital stay, cost, functional capacity, and Kansas City Cardiomyopathy Questionnaire (KCCQ) heart failure score were recorded at admission, 1-week, and 30-days post-op.

RESULTS

The mean () age of the 17 patients was 68.4 (8.0) years and 15 (88%) were female. Pre-surgical assessment identified 8 patients (47%) at high risk of PPCs. A total of 9 patients (53%) developed PPCs between the 1st and 3rd day post-surgery, and 7 of these 9 patients were amongst the 8 predicted as "high risk" prior to surgery. One patient died before the 30 day follow up. Pre-operative pulmonary risk assessment score, diabetes mellitus, a low baseline MIP and 6MWD were associated with a high incidence of PPCs. Compared to those without PPCs, patients with PPCs had longer ICU and hospital stay, and higher hospitalization cost. At 30 days post-surgery, patients without PPCs maintained higher MIP and 6MWD compared to those with PPCs, but there were no significant between-group differences in other lung function parameters nor KCCQ.

CONCLUSION

This is the first study to report the incidence of PPCs post TTVI. Despite a 3-day prehabilitation protocol and standard post-operative physiotherapy, PPCs were common among patients after TTVI and significantly impacted on hospital and short-term recovery and outcomes. In the majority of patients, PPCs could be accurately predicted before surgery. A comprehensive prehabilitation program should be considered for patients prior to TTVI.

CLINICAL TRIAL REGISTRATION

[www.ClinicalTrials.gov], identifier [ChiCTR2000039671].

摘要

目的

研究经导管三尖瓣植入术(TTVI)后肺部并发症(PPCs)的发生率及短期恢复情况。

方法

本研究纳入了17例诊断为严重三尖瓣反流并接受LuX瓣膜TTVI的患者。记录肺活量测定肺功能、最大吸气压力(MIP)和6分钟步行试验距离(6MWD)。术前,根据已发表的预定义标准将患者分为高或低肺风险组。一名物理治疗师在术前3天为所有患者提供关于胸廓扩张运动、有效咳嗽和以MIP的50%进行吸气肌训练方案的教育。所有患者均接受标准的术后物理治疗干预,包括体位摆放、胸廓扩张运动、分泌物清除技术和活动。根据墨尔本组评分第2版对患者进行PPCs评估。记录入院时、术后1周和30天时的临床特征、住院时间、费用、功能能力和堪萨斯城心肌病问卷(KCCQ)心力衰竭评分。

结果

17例患者的平均年龄为68.4(8.0)岁,15例(88%)为女性。术前评估确定8例患者(47%)有发生PPCs的高风险。共有9例患者(53%)在术后第1天至第3天发生PPCs,这9例患者中有7例在术前被预测为“高风险”。1例患者在30天随访前死亡。术前肺风险评估评分、糖尿病、较低的基线MIP和6MWD与PPCs的高发生率相关。与未发生PPCs的患者相比,发生PPCs的患者ICU和住院时间更长,住院费用更高。术后30天时,未发生PPCs的患者与发生PPCs的患者相比,MIP和6MWD更高,但两组在其他肺功能参数和KCCQ方面无显著差异。

结论

这是第一项报告TTVI后PPCs发生率的研究。尽管有3天的术前康复方案和标准的术后物理治疗,但PPCs在TTVI后的患者中很常见,并且对住院和短期恢复及结局有显著影响。在大多数患者中,PPCs在手术前可以被准确预测。TTVI术前应考虑为患者制定全面的术前康复计划。

临床试验注册

[www.ClinicalTrials.gov],标识符[ChiCTR2000039671]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/1a007c2df36a/fcvm-09-904961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/72f9ea1b1dbb/fcvm-09-904961-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/a93cab3a03d1/fcvm-09-904961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/1a007c2df36a/fcvm-09-904961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/72f9ea1b1dbb/fcvm-09-904961-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/a93cab3a03d1/fcvm-09-904961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d1/9160231/1a007c2df36a/fcvm-09-904961-g003.jpg

相似文献

1
Postoperative Pulmonary Complications in Patients With Transcatheter Tricuspid Valve Implantation-Implications for Physiotherapists.经导管三尖瓣植入患者的术后肺部并发症——对物理治疗师的启示
Front Cardiovasc Med. 2022 May 19;9:904961. doi: 10.3389/fcvm.2022.904961. eCollection 2022.
2
Durability of benefit after transcatheter tricuspid valve intervention: insights from actigraphy.经导管三尖瓣介入治疗后获益的持久性:活动记录仪的观察结果。
Eur J Heart Fail. 2022 Jul;24(7):1293-1301. doi: 10.1002/ejhf.2467. Epub 2022 Mar 21.
3
A Three-Day Prehabilitation Program is Cost-Effective for Preventing Pulmonary Complications after Heart Valve Surgery: A Health Economic Analysis of a Randomized Trial.一项为期三天的术前康复计划在预防心脏瓣膜手术后肺部并发症方面具有成本效益:一项随机试验的卫生经济学分析。
Rev Cardiovasc Med. 2024 Sep 10;25(9):323. doi: 10.31083/j.rcm2509323. eCollection 2024 Sep.
4
Burden of Heart Failure in Patients With Tricuspid Regurgitation and Effect of Transcatheter Repair on Different Subdimensions of Quality of Life.三尖瓣反流患者心力衰竭的负担和经导管修复对不同生活质量亚维度的影响。
J Am Heart Assoc. 2024 Aug 20;13(16):e034112. doi: 10.1161/JAHA.124.034112. Epub 2024 Aug 13.
5
Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation.堪萨斯城心肌病问卷在三尖瓣反流患者中的验证
JAMA Cardiol. 2025 Feb 1;10(2):117-125. doi: 10.1001/jamacardio.2024.4266.
6
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE.经导管三尖瓣介入治疗后死亡率和心力衰竭住院的预测:TRISCORE 的验证。
JACC Cardiovasc Interv. 2024 Apr 8;17(7):859-870. doi: 10.1016/j.jcin.2024.02.013.
7
Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation.经导管三尖瓣介入治疗三尖瓣反流患者的性别相关特征和短期结局。
Eur Heart J. 2023 Mar 7;44(10):822-832. doi: 10.1093/eurheartj/ehac735.
8
Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.经导管三尖瓣介入治疗后的结局:国际三尖瓣注册研究的中期结果。
JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.
9
Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registry.重度三尖瓣反流的充血模式与经导管治疗:来自多中心注册研究的见解
Eur J Heart Fail. 2024 Apr;26(4):1004-1014. doi: 10.1002/ejhf.3235. Epub 2024 Apr 4.
10
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.经导管二尖瓣置换术治疗伴有起搏器或除颤器导线患者的结局:来自三尖瓣注册研究的数据。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):554-564. doi: 10.1016/j.jcin.2019.10.058. Epub 2020 Jan 15.

引用本文的文献

1
Efficacy and Safety of Transcatheter Tricuspid Valve Replacement in Patients With Moderate to Severe Tricuspid Regurgitation: A Systematic Review and Meta-Analysis on Clinical Outcomes and Echocardiographic Indices.经导管三尖瓣置换术治疗中重度三尖瓣反流患者的疗效和安全性:临床结局及超声心动图指标的系统评价和荟萃分析
Health Sci Rep. 2025 Jun 23;8(6):e70950. doi: 10.1002/hsr2.70950. eCollection 2025 Jun.
2
Exploring the assessment of post-cardiac valve surgery pulmonary complication risks through the integration of wearable continuous physiological and clinical data.通过整合可穿戴式连续生理和临床数据探索心脏瓣膜置换术后肺部并发症风险评估
BMC Med Inform Decis Mak. 2025 Jan 31;25(1):47. doi: 10.1186/s12911-025-02875-2.
3

本文引用的文献

1
Incidence of community-acquired pneumonia in urban China: A national population-based study.中国城市社区获得性肺炎的发病率:一项全国性基于人群的研究。
Vaccine. 2020 Dec 14;38(52):8362-8370. doi: 10.1016/j.vaccine.2020.11.004. Epub 2020 Nov 13.
2
Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: a health economic analysis of a multicentre randomised trial.术前物理治疗可降低腹部大手术后肺部并发症的发生率:一项多中心随机试验的卫生经济学分析。
J Physiother. 2020 Jul;66(3):180-187. doi: 10.1016/j.jphys.2020.06.005. Epub 2020 Jul 14.
3
First-in-Man Experience of Transcatheter Tricuspid Valve Replacement With LuX-Valve in High-Risk Tricuspid Regurgitation Patients.
Transjugular tricuspid valve-in-ring replacement using the novel system under three-dimensional printing guidance.
经三维打印引导的新型系统行经皮三尖瓣瓣环置换术。
ESC Heart Fail. 2024 Feb;11(1):581-586. doi: 10.1002/ehf2.14589. Epub 2023 Nov 20.
4
A first-in-human study of transjugular transcatheter tricuspid valve replacement with the LuX-Valve Plus system.一项使用LuX-Valve Plus系统经颈静脉进行经导管三尖瓣置换的人体首例研究。
EuroIntervention. 2023 Feb 6;18(13):e1088-e1089. doi: 10.4244/EIJ-D-22-00517.
在高危三尖瓣反流患者中使用LuX瓣膜进行经导管三尖瓣置换术的首例人体经验。
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1614-1616. doi: 10.1016/j.jcin.2020.03.026.
4
Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience.经导管 PASCAL 瓣膜修复系统治疗重度三尖瓣反流的同情使用:多中心、观察性、首例人体经验。
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2488-2495. doi: 10.1016/j.jcin.2019.09.046.
5
Current outcomes of tricuspid valve surgery.三尖瓣手术的当前结果。
Prog Cardiovasc Dis. 2019 Nov-Dec;62(6):463-466. doi: 10.1016/j.pcad.2019.11.014. Epub 2019 Dec 2.
6
The effect of preoperative respiratory physiotherapy and motor exercise in patients undergoing elective cardiac surgery: short-term results.术前呼吸物理治疗和运动锻炼对择期心脏手术患者的影响:短期结果
Kardiochir Torakochirurgia Pol. 2019 Jul;16(2):81-87. doi: 10.5114/kitp.2019.86360. Epub 2019 Jun 28.
7
Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications after Cardiac Surgery.心脏手术后的术中机械通气和术后肺部并发症。
Anesthesiology. 2019 Nov;131(5):1046-1062. doi: 10.1097/ALN.0000000000002909.
8
Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.经导管三尖瓣修复系统治疗重度三尖瓣反流的长期结果:首例人体经验的见解。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1438-1447. doi: 10.1016/j.jcin.2019.04.038.
9
Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function.经导管三尖瓣修复术治疗重度三尖瓣反流对肝肾功能的影响。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1413-1420. doi: 10.1016/j.jcin.2019.04.018. Epub 2019 May 21.
10
6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation.三尖瓣重建治疗重度三尖瓣反流患者的 6 个月结果。
J Am Coll Cardiol. 2019 Apr 23;73(15):1905-1915. doi: 10.1016/j.jacc.2019.01.062.